JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110297200 on March 5, 2002

J. Biol. Chem., Vol. 277, Issue 24, 21643-21649, June 14, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/24/21643    most recent
M110297200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masaike, T.
Right arrow Articles by Yoshida, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masaike, T.
Right arrow Articles by Yoshida, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

F1-ATPase Changes Its Conformations upon Phosphate Release*

Tomoko MasaikeDagger §, Eiro MuneyukiDagger , Hiroyuki Noji||, Kazuhiko Kinosita Jr.**Dagger Dagger , and Masasuke YoshidaDagger Dagger Dagger §§¶¶

From the Dagger  Chemical Resources Laboratory, Tokyo Institute of Technology, 4259 Nagatsuta, Yokohama, 226-8503, Japan,  PRESTO (Precursory Research for Embryonic Science and Technology), Japan Science and Technology Corporation 332-0012, Japan, the || Institute of Industrial Science, University of Tokyo, 4-6-1 Komaba Meguro-ku, Tokyo 153-8505, Japan, the ** Center for Integrative Bioscience, Okazaki National Research Institutes, 38 Aza Nishigonaka, Myodaiji-Cho, Okazaki, Aichi, 444-8585, Japan, Dagger Dagger  CREST (Core Research for Evolutional Science and Technology) Genetic Programming Team 13, Teikyo University Biotechnology Center 3F, 907 Nogawa, Miyamae-ku, Kawasaki 216-0001, Japan, and §§ ERATO (Exploratory Research for Advanced Technology), Japan Science and Technology Corporation 332-0012, Japan

Received for publication, October 26, 2001, and in revised form, March 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Motor proteins, myosin, and kinesin have gamma -phosphate sensors in the switch II loop that play key roles in conformational changes that support motility. Here we report that a rotary motor, F1-ATPase, also changes its conformations upon phosphate release. The tryptophan mutation was introduced into Arg-333 in the beta  subunit of F1-ATPase from thermophilic Bacillus PS3 as a probe of conformational changes. This residue interacts with the switch II loop (residues 308-315) of the beta  subunit in a nucleotide-bound conformation. The addition of ATP to the mutant F1 subcomplex alpha 3beta (R333W)3gamma caused transient increase and subsequent decay of the Trp fluorescence. The increase was caused by conformational changes on ATP binding. The rate of decay agreed well with that of phosphate release monitored by phosphate-binding protein assays. This is the first evidence that the beta  subunit changes its conformation upon phosphate release, which may share a common mechanism of exerting motility with other motor proteins.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

ATP synthase is composed of the major subcomplexes F1 and Fo. F1-catalyzed synthesis of ATP from ADP and Pi is coupled with proton translocation through Fo, which resides in the membrane. F1 part can be separated from Fo part as a water-soluble ATPase that has subunit composition alpha 3beta 3gamma delta epsilon and hence is often called F1-ATPase. Catalytic nucleotide-binding sites are located on the beta  subunits, whereas the alpha  subunits contain noncatalytic nucleotide-binding sites. In the crystal structure of the bovine mitochondrial F1-ATPase (MF1),1 the coiled-coil structure of the gamma  subunit is surrounded by a semi-hexagonal ring of alpha 3beta 3 (1). F1-ATPase is a rotary motor enzyme; ATP-dependent rotation of the gamma  subunit relative to the alpha 3beta 3 ring, as predicted by biochemical studies (2-4), was visualized using the thermophilic F1-ATPase (TF1) (5). Consistent with the presence of three beta  subunits in the ring, hydrolysis of a single ATP molecule drives a 120° rotation of the gamma  subunit (6). It is intriguing how the local conformational changes accompanied by each of reaction steps in the catalytic cycle, such as ATP binding, hydrolysis, and release of ADP and Pi, are amplified and transformed into the force to dislocate the gamma  subunit. Recent progress shows that each 120° rotation is further divided into a 90° substep that is driven by ATP binding and a 30° substep presumably driven by the release of the product, most likely ADP (7).

Nucleotide binding induces a large conformational change of the beta  subunit (8). Each of the three beta  subunits in the initial MF1 structure, which was disclosed in 1994 (1), takes one of the two conformations: an "open" form in which catalytic site is empty or a "closed" form in which the catalytic site is occupied by AMP-PNP or ADP. Consistent with that, the beta  subunits of the crystal structure of the TF1 subcomplex alpha 3beta 3 without bound nucleotides were all in the open form (9). Compared with the open form, the carboxyl-terminal domain of the beta  subunit in the closed form swings ~30° toward the amino-terminal domain so that the catalytic cleft located between two domains is closed. A nucleotide-induced transition from the open to the closed conformation is inherent in the nature of the beta  subunit, because even the isolated beta  subunit undergoes the open-close motion responding to nucleotide binding (10, 11). Thus, it has been proposed that the coordinated open-to-closed and closed-to-open motions of the beta  subunits in F1-ATPase accompanied by ATP binding and ADP release drive 90° and 30° rotations of the gamma  subunit, respectively.

In contrast to the nucleotide-dependent open-close motion, the conformational events of the beta  subunit at the steps of hydrolysis of ATP and release of Pi are unclear. In the case of other ATP-driven motor proteins, myosin and kinesin, the structures of the ATP-bound form and the ADP-bound form are different (12, 13), and Pi release is assumed to be the step of power stroke (14, 15). The initial structure of MF1, however, shows that the ADP-bound beta  subunit and the AMP-PNP-bound beta  subunit are in a very similar, closed conformation. Therefore, it appears that the loss of Pi from the catalytic site does not cause significant conformational changes or that the intermediate species of the enzyme generated upon Pi release is too unstable to form crystals even though its conformation is different from the known structures. Indeed, a third conformation of the beta  subunit was reported recently (16); one of the beta  subunits in the AlF4--inhibited MF1 exists in a "half-closed" conformation, the catalytic site of which is occupied by ADP and sulfate in mimicry of Pi. Biochemical studies on the kinetics of Pi release and the related conformational changes are few, mainly because of the absence of methods to monitor Pi release from F1-ATPase.

The present work has aimed at real time monitoring of conformational changes of the beta  subunit caused by Pi release. Some Trp residues introduced into the beta  subunits of Escherichia coli F1-ATPase were reported to confer different fluorescence between AMP-PNP binding and ADP binding (17-19). Fluorescently labeled gamma  subunit was also reported to change its conformations upon ATP cleavage (20, 21). Nevertheless, none of them reported fluorescence changes of the beta  subunit caused by Pi release by time-resolved measurements. We have sought for new positions for the Trp mutation that can monitor changes of fluorescence upon Pi release. Concurrently for that purpose, we have adopted the Pi-binding protein that enabled real time monitoring of Pi release from the enzyme. Analyses, including kinetic comparison of fluorescence changes and Pi release after addition of ATP, have established that a Trp introduced at position 333 (R333W) reflects Pi release well. The residue 333 of the beta  subunit, located in helix H, which interacts with the "switch II loop," appears to sense gamma -phosphate of the bound nucleotide and changes its conformation upon loss of Pi from the catalytic site.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents and Buffers-- Nucleotides were purchased from Sigma and Roche Molecular Biochemicals. Mop reagents 7-methylguanosine and purine nucleotide phosphorylase were purchased from Sigma. The fluorescent probe for phosphate-binding protein, [2-(1-maleimidyl)ethyl]-7-(diethylamino)-coumarin-3-carboxamide (MDCC) was purchased from Molecular Probes. The buffers used in the measurements are abbreviated as follows: TK buffer, 50 mM Tris-HCl, pH 8.0, 100 mM KCl; TKM2 buffer, 50 mM Tris-HCl, pH 8.0, 100 mM KCl, 2 mM MgCl2; TKM4 buffer, 50 mM Tris-HCl, pH 8.0, 100 mM KCl, 4 mM MgCl2; KPi buffer, 100 mM KPi, pH 7.0, 100 mM KCl, 2 mM EDTA; NaPi buffer, 100 mM NaPi, pH 7.0, 200 mM NaCl; and reverse phase buffer: 100 mM NaPi, pH 6.9, 4 mM EDTA. Unless otherwise indicated, TKM2 buffer was used for measurements. To eliminate contaminated Pi from buffers, TKM and TK buffers for PBP assays contain 200 µM 7-methylguanosine and 0.01 unit/ml purine nucleotide phosphorylase (named Pi mop) (22, 23).

Strains, Plasmids, and Preparation of Subcomplexes-- E. coli strain JM109 was used for plasmid amplification. JM103Delta (uncB-uncD) was used for overexpression of the alpha , beta , and gamma  subunits of F1-ATPase. Plasmids used were pucbeta , which carried a gene for the beta  subunit, for mutagenesis and expression, and pkkalpha gamma , which carried genes for the alpha  and gamma  subunits, for expression. The beta R333W and beta D311W mutations into the beta  subunit were introduced by the Kunkel method (24) using primer oligonucleotides annealed to the single strand DNA of pucbeta : 5'-GATAAATCCCCATCTCCGCAAGCTTCCACTCCAGGTTCGTC-3' for beta R333W introducing cleavage site of HindIII and 5'-CGTCGTGGCCGGAGCCGGATCCGTATAGTCCCAGGCCGGGACGTAAATC-3' for beta D311W introducing cleavage site of BamHI (mutated bases are underlined). For preparation of the isolated beta (R333W) and alpha 3beta (D311W)3gamma , mutated plasmids were transformed into JM103Delta (uncB-uncD) for overexpression and purified using NaPi buffer as previously described (25). Because alpha 3beta (R333W)3gamma and alpha 3beta (D311W/R333W)3gamma could not be expressed using the pkkalpha gamma beta system, a novel lysate reassembly method was developed. The plasmids pkkalpha gamma , pucbeta (R333W), and pucbeta (D311W/R333W) were each expressed separately in JM103Delta (uncB-uncD). Pellets from centrifugation of the cultures were diluted in NaPi buffer. The cells containing mutated beta  subunits were each mixed with those containing the alpha  and gamma  subunits. The mixture was disrupted by a French pressure cell and was incubated at 30 °C for 30 min for reassembly of the subcomplex. It was then incubated at 60 °C for 15 min, and the insoluble denatured proteins were removed by centrifugation for 40 min at 40,000 rpm. Purification of the subcomplexes were performed by ammonium sulfate gradient in NaPi buffer using a Butyl-Toyopearl 650M column (Tosoh). The purified beta  subunit and subcomplexes were stored as ammonium sulfate precipitates. They were diluted in TK buffer, concentrated by Vivaspin (Sartorius), and applied twice to a gel filtration (Superdex 200; Amersham Biosciences) for final purification (flow was 0.5 ml/min first with TK buffer and second with KPi buffer) on the day of measurements.

Analyses of Bound Nucleotides-- Analysis of residual nucleotides after purification of the enzyme was performed as previously described (26). The number of residual nucleotides bound to alpha 3beta (R333W)3gamma was less than 0.1 mol/mol after gel filtration with KPi buffer and TK buffer.

The number of nucleotides bound to alpha 3beta (R333W)3gamma at the end points of the fluorescence measurements was estimated by the following protocol. The mixtures of nucleotides and alpha 3beta (R333W)3gamma from stopped flow measurements were each applied to an Ultrafree filtration device (molecular weight, 5 k cutoff; Millipore). After centrifugation for 2 min at 2 kilorounds per minute at 25 °C, the nucleotide contents in 100 µl of the filtrates were quantified by reverse phase high pressure liquid chromatography (ODS-80Ts; Tosoh) using reverse phase buffer. The amount of nucleotides bound to alpha 3beta (R333W)3gamma was estimated by subtracting the concentration of the nucleotides free in solution (concentration in the filtrate) from the initial concentration.

Measurements of Trp Fluorescence-- The fluorescence measurements of the Trp mutant subcomplexes and the isolated beta (R333W) subunit were carried out by excitation at 295 nm, and detection of emission at 345 nm was carried out using a spectrofluorometer (FP-6500; Jasco). In a cuvette, 1.2 ml of 5 µM beta (R333W) or 1 µM alpha 3beta 3gamma mutants was mixed with 20 µl of ATP or ADP while stirring.

Measurements of alpha 3beta (R333W)3gamma were carried out also by a stopped flow apparatus (SFM-400; BioLogic) using a xenon lamp as a source of light. ATP in TK buffer (30 µl of 1.0 or 0.5 or 0.25 µM)2 was mixed with the same volume of 2 µM alpha 3beta (R333W)3gamma in TKM4 buffer over 20 ms. The same method was applied to ADP, AMP-PNP, and ADPgamma S. TK buffer prevents ATP at submicromolar concentrations from decomposition into ADP and Pi before addition to alpha 3beta (R333W)3gamma . The same stopped flow experiments were also performed using buffers that were treated with Pi mop to ensure that the buffer conditions were the same as those used for measurement of Pi release. There was no change in the Trp fluorescence profile between with and without Pi mop in solutions (data not shown).

Measurement of Unisite Catalysis-- The unisite catalysis was measured using the stopped flow apparatus in the quenched flow mode. It was started by mixing 250 µl of 2 µM alpha 3beta (R333W)3gamma with the same volume of 1 µM ATP and stopped after various time periods by perchloric acid quenching. Hydrolyzed nucleotides were analyzed by a reverse phase column (ODS-80Ts; Tosoh) using the reverse phase buffer as previously described (26).

Measurement of Pi Release-- Release of Pi from alpha 3beta (R333W)3gamma was measured using a PBP assay (22, 23). PBP labeled with MDCC was prepared as previously described (22, 23). Binding of Pi to MDCC-labeled PBP (MDCC-PBP) increases the fluorescence emission at 464 nm when the complex is excited at 425 nm. By virtue of rapid binding of Pi to MDCC-PBP (kon = 1.36 × 108 M-1 s-1) and high affinity of PBP for Pi (Kd = ~0.1 µM) (22), the increase in the Pi concentration in the solutions could be monitored as the increase of fluorescence emission in real time.

PBP assays were carried out using a stopped flow apparatus (SFM-400; BioLogic) under the same conditions as the Trp fluorescence measurements. 30 µl of 2 µM alpha 3beta (R333W)3gamma in TKM4 buffer was mixed with the same volume of 4 µM MDCC-PBP and 1 µM ATP in TK buffer. The buffers contain Pi mop for elimination of Pi to avoid saturation of MDCC-PBP with contaminated Pi.

Measurement of the Rate of Formation of the MgADP-inhibited Form-- To estimate the rate of formation of the MgADP-inhibited form under the fluorescence measurement conditions, the following experiment was carried out. 20 µl of 11 µM alpha 3beta (R333W)3gamma and 200 µl of 0.55 µM ATP were manually mixed and preincubated at 25 °C for varying periods of time. 150 µl of the incubated solution was injected into the ATP-regenerating system (27) containing 2 mM ATP-Mg (mixture of equal concentrations of ATP and MgCl2) in TKM2 buffer. The time course of ATP hydrolysis was measured by monitoring the absorbance at 340 nm using a spectrophotometer (V-550; Jasco). The slope of the absorbance is initially small as the majority of the molecules are in the MgADP-inhibited form, but it gradually increases because of reactivation by binding of ATP to the alpha  subunit (28). Therefore, the ratio of active alpha 3beta (R333W)3gamma was estimated from the initial slope of 10 s of absorbance at 340 nm compared with that without preincubation.

Other Assays-- The concentrations of beta (R333W), alpha 3beta (R333W)3gamma , alpha 3beta (D311W/R333W)3gamma , and alpha 3beta (D311W)3gamma were analyzed by BCA assay (Pierce) and absorbance at 280 nm.

Data Processing-- Data processing was performed by BioKine software (BioLogic), Origin 6.0 (Microcal Software), Excel 97 (Microsoft), and Dynafit (BioKin) (29).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Transient Increase in Trp Fluorescence upon ATP Binding-- The initial crystal structure of MF1 suggests that Arg-333 in TF1-beta (Arg-337 in MF1-beta ) in helix H interacts with Asp-311 in TF1-beta (Asp-315 in MF1-beta ) of the switch II loop only when the beta  subunit is in the closed conformation (Fig. 1) (1). Ren et al. (30) showed that cysteines introduced at positions 311 and 333 of TF1-beta can readily form an intramolecular cross-link in two of the three beta  subunits in the alpha 3beta 3gamma subcomplex of TF1. Cross-linking abolished ATPase activity almost completely by fixing two beta  subunits in the closed conformation. We introduced Trps into the same positions and examined the fluorescence response of the mutant, expecting to have enabled fluorescent detection of nucleotide-induced open-close motion of the beta  subunits. Trp fluorescence of 1 µM alpha 3beta (D311W/R333W)3gamma subcomplex decreased when 0.5 µM ADP was added (Fig. 2A). The fluorescent response to the same concentration of ATP was very different from that observed for ADP; a transient fluorescence increase was followed by rapid decay. The final level of fluorescence after decay was similar to that attained by ADP. Then, to determine which (or both) Trp was responsible for this transient fluorescence change, we made two single mutants, alpha 3beta (D311W)3gamma and alpha 3beta (R333W)3gamma . The fluorescence response of alpha 3beta (D311W)3gamma to ADP was similar to that of ATP, that is, a similar extent of increase and no further rapid changes (Fig. 2B). On the other hand, fluorescence of alpha 3beta (R333W)3gamma showed a two-phase response to ATP addition: transient increase and rapid decay (Fig. 2C). The addition of ADP caused only a slight increase in fluorescence. The final level of fluorescence change by ATP was almost the same as that attained by ADP. It appeared that these two phases might represent certain steps in the catalysis occurring at a single catalytic site. Therefore, further fluorescence measurements were focused on alpha 3beta (R333W)3gamma , using a stopped flow apparatus, which could provide higher time resolution than manual mixing. It should be added that the three mutants mentioned above retained ATPase activity of rotary catalysis at a saturating ATP concentration (2 mM): 140 turnovers/s (alpha 3beta (D311W/R333W)3gamma ), 29 turnovers/s (alpha 3beta (D311W)3gamma ), and 106 turnovers/s (alpha 3beta (R333W)3gamma ), which are 61, 13, and 46%, respectively, of that of the alpha 3beta 3gamma subcomplex without these mutations. Hereafter, we focus on the characteristics of alpha 3beta (R333W)3gamma .


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Positions of the residues Asp-315 and Arg-337 in bovine mitochondrial F1 beta  subunit. AMP-PNP and residues Asp-315 and Arg-337 are shown as space-filling models. The switch II loop is in red, and gamma -phosphate of the bound nucleotide is in white. A, beta  subunit in the AMP-PNP bound form and the gamma  subunit. B and C, close-ups of the regions of Asp-315 and Arg-337 in AMP-PNP-bound beta  subunit (B) and nucleotide-free beta  subunit (C).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Time courses of fluorescence changes of the Trp mutants. At the times indicated by arrowheads, ATP or ADP was manually mixed with alpha 3beta (D311W/R333W)3gamma (A), alpha 3beta (D311W)3gamma (B), and alpha 3beta (R333W)3gamma (C). The concentrations of subcomplexes and nucleotides in the mixtures were 1 and 0.5 µM, respectively. The details of the experiments are described under "Experimental Procedures."

Isolated beta (R333W) Responds to ATP and ADP Differently-- To understand whether the different fluorescence response of alpha 3beta (R333W)3gamma to ATP or ADP is generated from intersubunit interaction in the subcomplex or from conformational changes within a beta  subunit, fluorescence response of the isolated beta (R333W) subunit to ATP or ADP was examined. Because the isolated beta  subunit can bind nucleotide but does not retain catalytic ability (31), the nucleotide-induced change of Trp fluorescence of beta (R333W) can be solely attributed to the nucleotide binding. The addition of ATP or ADP to the isolated beta (R333W) caused an instantaneous increase in Trp fluorescence that was followed by a slow increase (~30 s), and the fluorescence remained constant after saturation (Fig. 3A). The reason for the slow increase is not known, but it is worth noting that the extent of the fluorescence increase by ATP is significantly larger than by ADP, just as observed for initial fluorescence increase of alpha 3beta (R333W)3gamma . The Kd values for ATP and ADP estimated from fluorescence changes at various concentrations of nucleotide (Fig. 3B) are similar to each other: 20 µM for ATP and 27 µM for ADP, consistent with the values reported previously (32). These results suggest that conformational changes within a beta  subunit induced by AT(D)P binding can explain the initial increase of fluorescence observed for the alpha 3beta (R333W)3gamma subcomplex. The different magnitude of fluorescence increase in response to ATP and ADP indicates that the Trp residue introduced at position 333 of the beta  subunit is able to sense the presence of gamma -phosphate of the bound adenine nucleotides, and this ability is inherent in the beta (R333W) subunit.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Trp fluorescence changes of the isolated beta (R333W) subunit induced by binding of ATP and ADP. A, time course of Trp fluorescence changes induced by manual mixing with ATP or ADP at the time indicated by an arrowhead. Final concentrations of the beta (R333W) subunit and nucleotides were 5 µM and 1 mM, respectively. B, the extent of Trp fluorescence changes of the isolated beta (R333W) subunit (final concentration, 5 µM) induced by manual mixing with various concentrations of ATP or ADP. The lines indicate fits for calculations of the dissociation constant (Kd) by the following equation: y = C·[1 + x + Kd - sqrt {(1 + x + Kd)2 - 4x}]/2. The details of the experiments are described under "Experimental Procedures."

Initial Fluorescence Increase Reflects ATP Binding-- For alpha 3beta (R333W)3gamma , the initial increase in fluorescence by the addition of ATP was our initial focus (Fig. 4). The addition of a nonhydrolyzable ATP analog, AMP-PNP, to alpha 3beta (R333W)3gamma induced an increase in fluorescence that was similar to that observed for ATP, but no subsequent decay was observed (Fig. 4A). Similarly, the decay was not observed for binding of ATP in the absence of Mg, where hydrolysis was blocked (data not shown). Another ATP analog, ATPgamma S, which is a poor substrate for F1, also induced a similar fluorescence increase (Fig. 4A) that was followed by a slower decay. Taken together, we concluded that the initial fluorescence increase reflected the occupation of a catalytic site of the beta  subunit by ATP (step 1 of Scheme 1). The rates of nucleotide binding calculated from the fluorescence changes of alpha 3beta (R333W)3gamma were (1.7 ± 0.3) ×107 M-1 s-1 for ATP, (4.1 ± 0.7) ×107 M-1 s-1 for ADP, (1.3 ± 0.0) ×106 M-1 s-1 for AMP-PNP, and (2.8 ± 0.2) ×107 M-1 s-1 for ATPgamma S.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Time courses of Trp fluorescence changes of alpha 3beta (R333W)3gamma induced by mixing with various nucleotides using a stopped flow apparatus. Final concentrations of alpha 3beta (R333W)3gamma and nucleotides were 1 and 0.5 µM, respectively. ATP is in black, ADP is in blue, AMP-PNP is in green, and ATPgamma S is in red. The base line is subtracted from each trace. The changes from the start of the measurements (18.6 ms) are plotted. A, changes in 4 s. A line overlaid with the trace of ATP is a simulation curve according to the following scheme: F1 + ATP right-arrow F1·ATP right-arrow F1·ADP·Pi right-arrow F1·ADP + Pi. The rate constants used for the simulation are kon = 1.4×107, kcat = 14.2, and koff = 2.73, assuming that the increase in Trp fluorescence occurs by binding of ATP and that the decay occurs by release of Pi from F1. These rate constants are within the standard error of those derived from measurements of ATP hydrolysis and Pi release in the following sections (see also Figs. 5 and 6 and Table I). B, changes in 0.4 s. The lines indicate fitting curves for calculating the binding rates (kon) by the following scheme: F1 + nucleotide right-arrow F1·nucleotide. In the case of ATP, the same fitting curve as A is shown. The details of the experiments are described under "Experimental Procedures."


View larger version (8K):
[in this window]
[in a new window]
 
Scheme 1.   Reaction scheme of uni-site ATP hydrolysis by F1 ATPase.

Nucleotide Binding Is Not the Cause of Fluorescence Decay-- Decay of the fluorescence of alpha 3beta (R333W)3gamma after the initial increase was observed under the conditions where unisite catalysis (33-35) was occurring and hence may correspond to a certain step of catalysis after the capture of ATP by a catalytic site. 0.5, 0.25, and 0.125 µM ATP caused the decay at comparable rates,3 which indicates that the binding step is not involved in the decay (time courses are not shown). From the time courses of Trp fluorescence upon the addition of various nucleotides (Fig. 4A), it is assumed that ATP hydrolysis or an event that occurs immediately after that causes fluorescence decay. Typically, a slowly hydrolyzed ATP analog, ATPgamma S, causes slow decay.

ATP Hydrolysis Precedes Fluorescence Decay-- To test the assumption described above, the time course of generation of ADP (step 2 of Scheme 1) was measured. alpha 3beta (R333W)3gamma and ATP were mixed using a stopped flow apparatus under the same conditions as the fluorescence measurements, and the reactions were stopped after various periods of time by the addition of perchloric acid. Acid quenching liberates substrates from denatured enzymes. Therefore, irrespective of whether the substrate is released or still bound to the enzyme, the generation of ADP can be detected by this method. The generation of ADP occurred with the rate constant of 14.4 s-1 (Fig. 5), which is greater than the rate of fluorescence decay (2.7 s-1; Fig. 4). Therefore, the cause of fluorescence decay can be assigned to a step after ATP hydrolysis such as Pi release and/or ADP release, etc. To determine which is the case, the release of ADP and Pi was examined.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Time course of ATP hydrolysis by alpha 3beta (R333W)3gamma under unisite conditions. The reactions were performed by the quenched flow mode of stopped flow apparatus. Concentrations of alpha 3beta (R333W)3gamma and nucleotides in the mixture were 1 and 0.5 µM, respectively. The reactions were stopped by the addition of perchloric acid, and the amounts of ATP and ADP were measured. The line is a fitting curve according to the following scheme: F1 + ATP right-arrow F1·ATP right-arrow F1·ADP·Pi using kon = 1.7 × 107. The details of the experiments are described under "Experimental Procedures."

ADP Remains Bound after Hydrolysis-- Analysis of the enzyme-bound nucleotides was carried out by sampling the mixtures of 1 µM alpha 3beta (R333W)3gamma and 0.5 µM nucleotides from stopped flow fluorescence measurements and applying them each to an Ultrafree filtration device. The amount of nucleotides in the filtrates was analyzed. Virtually all (92%) of the product ADP remained bound to the enzyme even after all of the ATP had been hydrolyzed (Table I). Therefore, it is not feasible to assign the fluorescence decay to ADP release as the cause of the fluorescence decrease. We also measured the amount of enzyme-bound nucleotide when ADP, AMP-PNP, and ATPgamma S were added. Again, nearly all of the added nucleotides were stably bound to the enzyme (Table I). Taking this into account, the highest Trp fluorescence level by ATP, ATPgamma S, and AMP-PNP (Fig. 4A) can be assigned to the gamma -phosphate (gamma -thiophosphate)-bound form.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Concentrations of nucleotides remained bound to 1 µM of alpha 3beta (R333W)3gamma after incubation with 0.5 µM of nucleotides
The samples were the same as those used for fluorescence observation using a stopped flow apparatus. ATP and ATPgamma S were detected as ADP because of hydrolysis by alpha 3beta (R333W)3gamma . The details of the experiments are described under "Experimental Procedures."

Pi Release Proceeds at the Same Rate as Fluorescence Decay-- To monitor the time course of Pi release from the enzyme (step 3 of Scheme 1), a PBP assay was adopted. Fluorescence of a coumarin-labeled PBP (MDCC-PBP) increases severalfold when Pi binds. The versatility of monitoring of Pi release from alpha 3beta (R333W)3gamma by the PBP assay was carefully assessed and established (see "Experimental Procedures"). Thus, real time, continuous monitoring of Pi released from F1-ATPase became possible for the first time. We found that Pi was released from alpha 3beta (R333W)3gamma with a rate constant of 2.8 ± 0.1 s-1 (Fig. 6), which is the same rate as that of the fluorescence decay (Fig. 4). Thus, it is suggested that the decay of fluorescence after the initial increase reflects the decay of the enzyme form with bound ADP-Pi to the enzyme form with bound ADP only, that is, release of Pi from the enzyme. However, if there is a rapid conversion from the active enzyme-ADP complex into inactive enzyme-ADP complex, this conversion is also a candidate for the fluorescence decay. This possibility should be considered because it is known that the so-called MgADP-inhibited form, an inactive form of enzyme-ADP complex, tends to be generated under these conditions. We examined this possibility next.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 6.   Time course of Pi release from alpha 3beta (R333W)3gamma monitored by fluorescence increase of MDCC-PBP. ATP was mixed with alpha 3beta (R333W)3gamma using a stopped flow apparatus. The final concentrations of alpha 3beta (R333W)3gamma and nucleotides were 1 and 0.5 µM, respectively. The saturated level of MDCC-PBP fluorescence is set 0.5 µM. For comparison, the profile of Trp fluorescence changes under the same conditions is superimposed (red). A blue line indicates the fit of the MDCC-PBP fluorescence by the following scheme: F1 + ATP right-arrow F1·ATP right-arrow F1·ADP·Pi right-arrow F1·ADP + Pi using kon = 1.7 × 107 and kcat = 14.4. The details of the experiments are described under "Experimental Procedures."

Transition to the MgADP-inhibited Form Is Slower than Fluorescence Decay-- The MgADP-inhibited form (step 4 of Scheme 1) is not caused by a mere product inhibition but by stable retention of MgADP at the catalytic site. The MgADP can either be picked up from the bulk phase medium or can be a remnant of hydrolysis that remains bound to the enzyme (27). When the MgADP-inhibited form of F1-ATPase is exposed to ATP and Mg2+, it shows no ATPase activity initially but is gradually reactivated with a time constant of ~30 s (27, 43). Therefore, the population of the MgADP-inhibited form in a certain preparation of F1-ATPase can be assessed from the initial rate of ATP hydrolysis. Under the same conditions used for the fluorescence measurement, we took an aliquot from the solution at the indicated times, injected it into the ATPase assay mixture and measured the initial ATPase activity. The initial ATPase activities were plotted as a function of the time and the rate of generation of the MgADP-inhibited form in the solution was estimated (Fig. 7). The time constant of the onset of MgADP inhibition thus estimated was 15 s, which is much slower than the fluorescence decay. Therefore, the possibility that the fluorescence decay is caused by generation of the MgADP-inhibited state is unlikely. In other words, the lifetime of active MgADP bound form is long enough to be maintained during fluorescence changes of several seconds. Taking these results together, we can conclude that under unisite conditions, the increase in Trp fluorescence of the alpha 3beta (R333W)3gamma subcomplex occurs upon ATP binding, and the decay occurs as a function of Pi release (Table II).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 7.   Formation of the MgADP-inhibited form under the unisite conditions. alpha 3beta (R333W)3gamma (1 µM) was preincubated with 0.5 µM ATP. An aliquot of the mixture was taken out after the indicated preincubation period and injected into the ATPase assay mixture, and an initial velocity of ATP hydrolysis was measured that reflected the proportion of the active form and the MgADP-inhibited form of the subcomplex generated during preincubation with ATP. The details of the experiments are described under "Experimental Procedures."

                              
View this table:
[in this window]
[in a new window]
 
Table II
Rate constants of the reaction steps and corresponding Trp fluorescence changes


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The novel Trp mutant alpha 3beta (R333W)3gamma revealed that the residue Arg-333 senses the presence of gamma -phosphate at the catalytic site of beta  subunit as well as changes in the surrounding structure upon nucleotide binding and Pi release. Although Arg-333 does not directly contact the gamma -phosphate of the bound nucleotide in the crystal structure, this residue somehow recognizes conformational differences between ATP-bound (or ADP-Pi-bound) and ADP-bound conformations of the beta  subunit.

It is worth noting that when a nucleotide is bound to the catalytic site, the mutated residue Arg-333 interacts with the switch II loop, a switch region common to a wide range of nucleotide triphosphate-utilizing proteins including GTP-binding proteins and motor proteins (12, 13, 36-40). A function of switch II in myosin and kinesin is to transmit conformational changes caused by gamma -phosphate release to a distant point where motility of motor proteins is exerted (41). For example, in the case of myosin, an alanine mutation introduced into Gly-457 in the switch II loop causes loss of motility (42). In the crystal structure of monomeric kinesin motor KIF1A, the switch II loops of the ADP-bound and ATP-bound forms were in different conformations (12). Moreover, studies using fluorescence energy transfer and other analyses of conventional kinesin indicated a difference between ATP-bound and ADP-bound forms in the flexibility of the neck linker (15). Therefore, it is natural to assume that F1-ATPase, another motor protein, might undergo an analogous conformational change when Pi is released.

However, real images of the conformational change of F1-ATPase that we detected by the fluorescence change cannot be directly assumed by comparing crystal structures of various nucleotide binding states that are solved to date. The crystal structure of F1-ATPase containing beta  subunits in the ATP-bound, ADP-bound, and empty forms in one molecule (1) suggested that Pi release does not cause drastic conformational changes because the structure of AMPPNP-bound and ADP-bound beta  subunits are very similar to each other, both in the same closed conformation. There is a possibility that introduced Trp reflects a very subtle change in the conformation accompanying Pi release. A new crystal structure (16) was discovered recently that contains a third half-closed conformation of the beta  subunit, which is in between the closed and open forms. This new conformation is thought to be in a transition state where the products ADP and Pi are both bound. The existence of this half-closed conformation indicated partial opening of the beta  subunit during ATP hydrolysis. As a next step, further opening of ADP-bound form induced by Pi release can naturally be assumed. Therefore, another possibility is that the fluorescence change reflects the difference of these two partially open states: one with bound ADP-Pi and the other with bound ADP. This problem has direct implications on the conformational transitions accompanying the catalytic cycle but awaits further studies to be clarified.

The present research also revealed new information about the ATPase reaction by direct, real time measurements of some of the kinetic parameters of the unisite catalysis (Table II). The parameters shown here give insights into the reaction mechanism. The first is the rate of nucleotide binding. Comparing the results of stopped flow measurements (unisite catalysis conditions) with the previous single molecule observation of rotating F1-ATPase at low ATP concentrations (bi-site or tri-site catalysis conditions), the rates of ATP binding are in the same range ((1.7 ± 0.3) ×107 M-1 s-1 and 2.7×107 M-1 s-1, respectively). This indicates that the rates of ATP binding are almost the same for the first and second (or third) catalytic sites. The second is that Pi release predominantly occurs while ADP remains bound to the enzyme in unisite catalysis. The third is that the rate of Pi release is slower than that of ATP hydrolysis, suggesting that the F1·ADP·Pi complex has to wait for some conformational change that allows Pi release.

Future studies should be directed at the observation of conformational changes of the beta  subunit in F1-ATPase at each step (including Pi release) of during rotational catalysis. For this purpose, a new probe that is tractable by single molecule observation is necessary.

    ACKNOWLEDGEMENTS

Dr. Martin R. Webb is gratefully acknowledged for advice on preparation and measurements of phosphate-binding protein. We thank K. Kawashima, Dr. Motojima, Dr. Kato-Yamada, Dr. Watanabe, Dr. Georges, Dr. T. Suzuki, Dr. Motohashi, Dr. Tabata, Dr. Hisabori, Dr. Taguchi, and J. Suzuki for valuable discussion and technical advice and Dr. Hardy for critically reading the manuscript.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by Fellowships of the Japan Society for the Promotion of Science for Young Scientists.

¶¶ To whom correspondence should be addressed. Tel.: 81-45-924-5233; Fax: 81-45-924-5277; E-mail: myoshida@res.titech.ac.jp.

Published, JBC Papers in Press, March 5, 2002, DOI 10.1074/jbc.M110297200

2 All the stopped flow measurements and bound nucleotide measurements were repeated with 75 µl of mixing shots to be sure that the effects of carry-over from the previous shots were minimum. The rate constants and the amount of bound nucleotides (except for AMP-PNP, 0.41 mol/mol in Table I) were essentially the same (± 5%) as those obtained with 30 µl/shot.

3 The rates of decay estimated by the simple fitting scheme F1 + ATP right-arrow F1·ATP right-arrow F1·ADP + Pi attributing fluorescence increase to binding of ATP and decay to hydrolysis were kdecay = 1.9 ± 0.3, 1.8, and 2.0 s-1 for 0.5, 0.25, and 0.125 µM ATP, respectively.

    ABBREVIATIONS

The abbreviations used are: MF1, bovine heart mitochondrial F1; TF1, thermophilic F1-ATPase; AMP-PNP, adenosine 5'-(beta ,gamma -imino)triphosphate; MDCC, [2-(1-maleimidyl)ethyl]-7-(diethylamino)-coumarin-3-carboxamide; PBP, phosphate-binding protein; ATPgamma S, adenosine 5'-O-(3-thiotriphosphate).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Abrahams, J. P., Leslie, A. G. W., Lutter, R., and Walker, J. E. (1994) Nature 370, 621-628[CrossRef][Medline] [Order article via Infotrieve]
2. Boyer, P. D. (1993) Biochim. Biophys. Acta 1140, 215-250[Medline] [Order article via Infotrieve]
3. Boyer, P. D., and Kohlbrenner, W. E. (1981) Energy Coupling in Photosynthesis , pp. 407-426, Elsevier Science Publishing Co., Inc., New York
4. Duncan, T. M., Bulygin, V. V., Zhou, Y., Hutcheon, M. L., and Cross, R. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10964-10968[Abstract/Free Full Text]
5. Noji, H., Yasuda, R., Yoshida, M., and Kinosita, K., Jr. (1997) Nature 386, 299-302[CrossRef][Medline] [Order article via Infotrieve]
6. Yasuda, R., Noji, H., Kinosita, K., Jr., and Yoshida, M. (1998) Cell 93, 1117-1124[CrossRef][Medline] [Order article via Infotrieve]
7. Yasuda, R., Noji, H., Yoshida, M., Kinosita, K. Jr., and Ito, H. (2001) Nature 410, 898-904[CrossRef][Medline] [Order article via Infotrieve]
8. Tsunoda, S. P., Muneyuki, E., Amano, T., Yoshida, M., and Noji, H. (1999) J. Biol. Chem. 274, 5701-5706[Abstract/Free Full Text]
9. Shirakihara, Y., Leslie, A. G. W., Abrahams, J. P., Walker, J. E., Ueda, T., Sekimoto, Y., Kambara, M., Saika, K., Kagawa, Y., and Yoshida, M. (1997) Structure 5, 825-836[Medline] [Order article via Infotrieve]
10. Tozawa, K., Sekino, N., Soga, M., Yagi, H., Yoshida, M., and Akutsu, H. (1995) FEBS Lett. 376, 190-194[CrossRef][Medline] [Order article via Infotrieve]
11. Yagi, H., Tozawa, K., Sekino, N., Iwabuchi, T., Yoshida, M., and Akutsu, H. (1999) Biophys. J. 77, 2175-2183[Abstract/Free Full Text]
12. Kikkawa, M., Sablin, E. P., Okada, Y., Yajima, H., Fletterick, R. J., and Hirokawa, N. (2001) Nature 411, 439-445[CrossRef][Medline] [Order article via Infotrieve]
13. Houdusse, A., Kalabokis, V. N., Himmel, D., Szent-Gyorgyi, A. G., and Cohen, C. (1999) Cell 97, 459-470[CrossRef][Medline] [Order article via Infotrieve]
14. Suzuki, Y., Yasunaga, T., Ohkura, R., Wakabayashi, T., and Sutoh, K. (1998) Nature 396, 380-383[CrossRef][Medline] [Order article via Infotrieve]
15. Rice, S., Lin, A. W., Safer, D., Hart, C. L., Naber, N., Carragher, B. O., Cain, S. M., Pechatnikova, E., Wilson-Kubalek, E. M., Whittaker, M., Pate, E., Cooke, R., Taylor, E. W., Milligan, R. A., and Vale, R. D. (1999) Nature 402, 778-783[CrossRef][Medline] [Order article via Infotrieve]
16. Menz, R. I., Walker, J. E., and Leslie, A. G. W. (2001) Cell 106, 331-341[CrossRef][Medline] [Order article via Infotrieve]
17. Weber, J., Wilke-Mounts, S., Lee, R. S.-F., Grell, E., and Senior, A. E. (1993) J. Biol. Chem. 268, 20126-20133[Abstract/Free Full Text]
18. Weber, J., Bowman, C., and Senior, A. E. (1996) J. Biol. Chem. 271, 18711-18718[Abstract/Free Full Text]
19. Weber, J., Wilke-Mounts, S., Hammond, S. T., and Senior, A. E. (1998) Biochemistry 37, 12042-12050[CrossRef][Medline] [Order article via Infotrieve]
20. Turina, P., and Capaldi, R. A. (1994) J. Biol. Chem. 269, 13465-13471[Abstract/Free Full Text]
21. Turina, P., and Capaldi, R. A. (1994) Biochemistry 33, 14275-14280[CrossRef][Medline] [Order article via Infotrieve]
22. Brune, M., Hunter, J. L., Corrie, J. E. T., and Webb, M. R. (1994) Biochemistry 33, 8262-8271[CrossRef][Medline] [Order article via Infotrieve]
23. Brune, M., Hunter, J. L., Howell, S. A., Martin, S. R., Hazlett, T. L., Corrie, J. E. T., and Webb, M. R. (1998) Biochemistry 37, 10370-10380[CrossRef][Medline] [Order article via Infotrieve]
24. Kunkel, T. A., Bebenek, K., and McClary, J. (1991) J. Methods Enzymol. 204, 125-139
25. Matsui, T., and Yoshida, M. (1995) Biochim. Biophys. Acta 1231, 139-146[Medline] [Order article via Infotrieve]
26. Hisabori, T., Muneyuki, E., Odaka, M., Yokoyama, K., Mochizuki, K., and Yoshida, M. (1992) J. Biol. Chem. 267, 4551-4556[Abstract/Free Full Text]
27. Matsui, T., Muneyuki, E., Honda, M., Allison, W. S., Dou, C., and Yoshida, M. (1997) J. Biol. Chem. 272, 8215-8221[Abstract/Free Full Text]
28. Jault, J. M., Matsui, T., Jault, F